Form D · Other Health Care
GeniPhys, Inc.
Indianapolis, IN · CIK 0001955873
Offering snapshot reported Feb 13, 2026 · SEC filing
- Reported sold
- $3M Offering amount: $5.55M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 29, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 13, 2026 | Initial | $2,999,910 | No comparison | 17 | SEC filing |
| Nov 29, 2022 | Initial | $4,450,300 | No comparison | 25 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-573561
Source: Form D, filed Feb 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John De Ford | Director |
| Andrew S Eibling | Director, Executive |
| Sherry L. Harbin | Director, Executive |
| Scot A. Harbin | Executive |
| Shaun Hawkins | Director |
| R. Matthew Neff | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
7750 Zionsville Road Suite 200
Indianapolis, IN, 46268
Indianapolis, IN, 46268